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Systemic Dissemination of Pneumocystis Carinii in a Patient with 
Acquired Immunodeficiency Syndrome 
Mahul B. Amin, MD,* Michael P. Abrash, MD,* Eugene Mezger, MD,* 
and Gary F. Sekerak, MD* 
Pneumocystis carinii is usually considered a respiratory tract pathogen; however, there are reported 
cases of limited and generalized dissemination of the organismfrom the lungs of immunocompromised 
patients. We present the autopsy findings of a 29-year-old male with acquired immunodeficiency 
syndrome (AIDS) and recurrent Pneumocystis carinii pneumonia who developed abnormal liver 
function tests. The patient had received aerosolized pentamidine because of toxic reactions to other 
modes of therapy. The postmortem examination revealed Pneumocystis in the lungs, liver, spleen, 
kidney, myocardium, thymus, pancreas, thyroid gland, bilateral parathyroid and adrenal glands, 
gastrointestinal mucosa, perihilar and mesenteric lymph nodes, and bone marrow. A high index of 
suspicion, especially in patients treated with aerosolized pentamidine, may lead to an increased 
recognition of disseminated pneumocystosis. Dissemination of the infection may be due to failure of 
the aerosolized drug to achieve adequate blood levels. As AIDS patients survive longer because of the 
developing therapeutic arsenal, disseminated pneumocystosis may be encountered wilh increasing 
frequency in these immunocompromised patients. (Henry Ford Hosp Med J 1990;38:68-71) 
P neumocystis carinii pneumonia (PCP) was a relatively un-common event, occurring usually in epidemics among mal-
nourished populations or as sporadic infections in immu-
nocompromised patients prior to the onset of acquired immu-
nodeficiency syndrome (AIDS). With an increasing incidence of 
AIDS, the incidence of PCP has also increased. In about 60% of 
individuals with AIDS, PCP is an initial manifestation of the 
disease, while 80% of them will develop one or more episodes 
during the course of their disease (1). 
The organism is usually confined to the respiratory tract, 
rarely extending beyond its confines to the hilar group of lymph 
nodes and occasionally to the spleen or liver. Isolated case re-
ports have described limited dissemination of infection to the 
bone marrow (2), choroid (3), spleen (4), extemal ear (5,6), mid-
dle ear (7), liver (8), smalt bowel (9), and thyroid (1). Gener-
alized dissemination of Pneumocystis (Pneumocystis involving 
multiple organs simultaneously) is exceptional and to our 
knowledge has thus far been reported at autopsy in only seven 
cases of AIDS (1,10-15). Earlier reports of generalized dissemi-
nated pneumocystosis in non-AIDS immunocompromised pa-
tients are also available (16-19). 
We present a case of disseminated pneumocystosis in an 
AIDS patient with recurrent PCP. 
Case History 
A 29-year-old male was diagnosed with AIDS when he had his first 
episode of PCP in August 1987. He was hospitalized for a second epi-
sode of PCP a year later Because of toxic reactions to intravenous tri-
methoprim-sulfamethoxazole (SXT) and pentamidine (rash and renal 
toxicity, respectively), he was treated with a 21-day course of aero-
solized pentamidine (600 mg/day). After discharge he received aero-
solized pentamidine 300 mg every two weeks. His medications in-
cluded azidothymidine (AZT) which was intermittently interrupted 
when he developed anemia requiring blood transfusions. A third hospi-
talization for PCP occurred in lanuary 1989, but only three days after 
discharge he was readmitted for increasing shortness of breath, weak-
ness, and progressive cough. 
Significant physical findings included fever (39°C [102.2°F], mild 
dyspnea, cervical adenopathy, and respiratory rhonchi overthe left lung 
base. Chest roentgenogram revealed a diffuse, bilateral reticulonodular 
infiltrate. Consolidation was severe in the perihilar regions and left mid 
lung. 
Initial laboratory studies revealed leukopenia (leukocyte counl 2.6 
lO'/L [2,600/p,L], 51% polycytes, 18% bands, 14% lymphocytes, 16% 
monocytes, 1% eosinophils), hemoglobin 125 g/L (12.5 g/dL), hema-
tocrit 0.36 (36%), and platelet count 10.8 W/L (108,000/M.L); serum 
electrolytes, BUN, creatinine, and glucose were normal. Semm lactic 
dehydrogenase (617 lU/L), GOT (110 lU/L), OPT (93 lU/L), alkaline 
phosphatase (4.7 |j.kat/L [279 lU/L]), and GOT (417 lU/L) were ele-
vated. The total semm protein and albumin were 40 g/L (4 g/dL) and 17 
g/L (1.7 g/dL), respectively. Blood cultures for aerobic and anaerobic 
bacteria, fungi, mycobacteria, and viruses revealed no isolates. Bron-
chial washings revealed no fungi or mycobacteria. 
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Fig 1—Lung: postfixation, showing mosaic linear pattern of 
softening and patchy cavitation (the asterisk indicates the major 
bronchus and the arrow the pulmonary artery). 
Fig 2—Liver section: postfixation, showing multiple discrete 
nodules, often coalescent. 
During the hospitalization, the patient had pancytopenia (WBC 
count 1.9 lO'/L [ I ,900/|JLL], hemoglobin 93 g/L [9.3 g/dL], and platelet 
count 8.9 mVL [89,000/(JLL]) and received transfusions. At this time, 
his medications included dapsone, AZT, aerosolized pentamidine, and 
aspirin. Despite increasing respiratory difficulty, he declined bron-
choscopy and open lung biopsy. Associated with the other abnormal 
liver function tests, he developed prolonged prothrombin time (14 sec-
onds; control 10.5 seconds) and activated partial thromboplastin time 
(55 seconds; normal range 22 to 36 seconds). 
The patient continued to deteriorate and died on the 22nd hospital 
day. A complele autopsy was performed but permit did not provide for 
examination of eyes. There was, however, no clinical evidence of 
retinitis. 
Autopsy Findings 
Cut surfaces of both lungs revealed a mosaic linear pattem of 
yellow-gray softening, seemingly in an interstitial pattem with 
patchy cavitation, measuring from less than 1 mm in the right 
upper lobe and up to 2 cm in the right tower tobe (Fig 1). No 
normal parenchyma was observed in either lung. Hilar lymph 
nodes were enlarged and showed simitar yellow-gray softening. 
Multiple discrete necrotic yellow-gray nodules, often coales-
cent, each measuring t to 3 mm were found in the liver (Fig 2), 
spleen, pancreas, kidneys, and mesenteric lymph nodes. Bilat-
eral pleural effusions and ascites were atso present. 
Microscopy 
Sections from both lungs showed PCP with confluent areas of 
necrosis and diffuse alveolar damage (Fig 3). Sections from the 
heart revealed focal myocytotysis with a distinctive granular ex-
udate devoid of leukocytes (Fig 4). Grocott stains revealed cysts 
of Pneumocystis carinii (Fig 5). 
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Fig 3—Lung histology showing characteristic granular exudate 
(arrowhead) within alveoli with pneumocyte hyperplasia 
(hematoxylin-eosin stain, XlOO). 
Fig 4—Heart histology; granular exudate (arrowhead) between 
myocardial fibers (hematoxylin-eosin stain, X66). 
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•* « Fig 5—Pulmonary alveolar exudate showing characteristic morphology o/Pneumocystis cysts (Grocott stain, X200). Fig 7—Kidney histology; area of necrosis with characteristic exudate (arrowhead) (hematoxylin-eosin stain, XSO). 
Fig 6—Liver histology; portal triad with characteristic exudate 
and cysts o/Pneumocystis carinii (arrow) (Grocott stain, X200). 
Sections from necrotic foci in hilar lymph nodes, liver (Fig 6), 
spleen, kidney (Fig 7), pancreas, and mesenteric lymph nodes 
revealed finely granular eosinophilic exudate which contained 
cysts of Pneumocystis carinii in Grocott stained sections. 
Random sections from the thymus, thyroid gland, para-
thyroid glands, gastrointestinal mucosa, bone manow (Fig 8), 
and both adrenal glands (Fig 9) revealed finely granular 
eosinophilic exudate. Again, Grocott stain revealed cysts of 
Pneumocystis carinii. 
Periodic acid-Schiff and acid-fast stains did not reveal any 
other organisms. No viral inclusions were recognized. The sec-
tions of central nervous system did not show any evidence of 
Pneumocystis carinii. Postmortem cultures of lung and liver 
tissue provided no bacterial, fungal, or viral isolates. 
Discussion 
Several questions arise in the analysis of cases of dissemi-
nated pneumocystosis. First, why does the organism appear 
confined to the lungs in most cases? Pneumocystis carinii is a 
saprophyte residing in the lung, and the alveolus is the natural 
habitat for the organism (20). Owing to the high incidence of 
PCP in AIDS patients, physicians are prompt in their approach 
to treat the symptomatic infection. However, the organisms may 
occasionally find their way to the reticuloendothelial system, 
from which they may intermittently seed the lungs (4). This lo-
cal spread may partially explain the high rate of recunence of 
PCP 
Second, what factors predispose to dissemination of the or-
ganism? All answers are only speculation. A constant feature in 
most cases of disseminated disease has been recunence of PCP. 
Pulmonary interstitial invasion and vascular invasion may result 
in an aggressive form of the disease which results in dissemina-
tion (2,10). In our case, vascular invasion was not demonstrated 
morphologically but presumably had occuned. Reported geo-
graphic differences in occunence of dissemination may be inter-
preted as representing strain differences (13). The theory that 
surgical manipulation (resection or biopsy) of infected lungs 
might explain dissemination (2,17) cannot account for atl cases, 
inctuding ours. If indeed surgery is a mechanism for dissemina-
tion, the risk must be tow, given the large numbers of AIDS pa-
tients who have had lung biopsies. Inability to comptetely eradi-
cate the Pneumocystis infection must be an important factor. In 
our case, toxic reactions to intravenous pentamidine and SXT 
led to treatment with aerosolized pentamidine. The aerosol 
route does not achieve systemic therapeutic levets reached with 
other routes of administration of pentamidine (21,22). This 
failure may be a key issue in the use of aerosolized pentamidine 
as a form of prophylactic therapy. Oral dapsone was admin-
istered briefly. Clinical trials with dapsone indicate that it is ef-
fective for Pneumocystis in only about half of the patients. Dap-
sone plus trimethoprim is considerably more effective (21,22). 
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Fig 8—Bone marrow histology; characteristic exudate (ar-
rowhead) amidst native hematopoietic cells and marrow fat 
(hematoxylin-eosin stain, XlOO). 
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Fi^ 9—Adrenal gland histology; characteristic exudate (ar-
rowhead) in the cortex (the solid arrow indicates the adrenal 
cortex, the hollow arrow the adrenal medulla, and the asterisk 
indicates the capsule) (hematoxylin-eosin stain, XlOO). 
Finally, what are the clues that indicate dissemination? When 
abnormal liver or renal function tests are encountered, dissemi-
nated pneumocystosis should be considered as a differential di-
agnosis along with other opportunisric infections, such as 
cytomegalovims, histoplasmosis, or toxoplasmosis. 
Including our case with the other seven reported permits these 
conclusions; 
1. Alt cases of disseminated pneumocystosis had recogniz-
able lesions at autopsy. Microscopically, inflammatory infiltrate 
was notably absent (gross and microscopic features of two cases 
were not described in detail). 
2. The central nervous system is conspicuously spared. How-
ever, cysts were detected in the Virchow-Robin space in one case 
(13) and in the pituitary in another (15). 
3. Antemortem diagnosis, made in one case only, was based 
on esophageal and duodenal biopsies (10). 
Disseminated pneumocystosis is a distinct but rarely recog-
nized entity. As the incidence of AIDS increases, an increased 
incidence of such cases is anticipated. "Highrisk" casesinclude 
those with recurrent PCP, whose therapy has been limited to 
aerosolized pentamidine, who have pulmonary interstitial and 
vascular invasion, and spread to hilar lymph nodes. Heightened 
surveillance of patients with abnormal organ function tests and a 
high index of suspicion while interpreting histologic material 
from high risk cases may result in increased recognition. 
Our case raises the issue of whether or not aerosol pen-
tamidine therapy, producing suboptimal systemic levels, may 
have allowed dissemination of the organism. 
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